Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.Fed Regist. 1998 Sep 29; 63(188):51825-7.FR
Abstract
The Food and Drug Administration (FDA) is amending certain regulations governing establishment registration and device listing by domestic distributors. These amendments are being made to implement revisions to the Federal Food, Drug, and Cosmetic Act (the act), as amended by the Food and Drug Modernization Act of 1997 (FDAMA). Elsewhere in this issue of the Federal Register, FDA is publishing a companion proposed rule, under FDA's usual procedures for notice and comment, to provide a procedural framework to finalize the rule in the event the agency receives any significant adverse comment and withdraws the direct final rule.
Pub Type(s)
Journal Article
Language
eng
PubMed ID
10185812
Citation
"Medical Devices; Establishment Registration and Device Listing for Manufacturers and Distributors of devices--FDA. Direct Final Rule." Federal Register, vol. 63, no. 188, 1998, pp. 51825-7.
Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule. Fed Regist. 1998;63(188):51825-7.
(1998). Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule. Federal Register, 63(188), 51825-7.
Medical Devices; Establishment Registration and Device Listing for Manufacturers and Distributors of devices--FDA. Direct Final Rule. Fed Regist. 1998 Sep 29;63(188):51825-7. PubMed PMID: 10185812.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
PY - 1998/9/2/pubmed
PY - 1998/9/2/medline
PY - 1998/9/2/entrez
SP - 51825
EP - 7
JF - Federal register
JO - Fed Regist
VL - 63
IS - 188
N2 - The Food and Drug Administration (FDA) is amending certain regulations governing establishment registration and device listing by domestic distributors. These amendments are being made to implement revisions to the Federal Food, Drug, and Cosmetic Act (the act), as amended by the Food and Drug Modernization Act of 1997 (FDAMA). Elsewhere in this issue of the Federal Register, FDA is publishing a companion proposed rule, under FDA's usual procedures for notice and comment, to provide a procedural framework to finalize the rule in the event the agency receives any significant adverse comment and withdraws the direct final rule.
SN - 0097-6326
UR - https://www.unboundmedicine.com/medline/citation/10185812/Medical_devices
DB - PRIME
DP - Unbound Medicine
ER -